The Clorox Company (CLX)
| Market Cap | 10.42B -29.2% |
| Revenue (ttm) | 6.72B -5.4% |
| Net Income | 587.00M -27.5% |
| EPS | 4.81 -26.2% |
| Shares Out | 120.93M |
| PE Ratio | 17.92 |
| Forward PE | 15.07 |
| Dividend | $5.00 (5.80%) |
| Ex-Dividend Date | Oct 28, 2026 |
| Volume | 3,060,562 |
| Open | 85.24 |
| Previous Close | 84.97 |
| Day's Range | 85.22 - 87.67 |
| 52-Week Range | 79.12 - 128.90 |
| Beta | 0.57 |
| Analysts | Hold |
| Price Target | 97.47 (+13.07%) |
| Earnings Date | Nov 2, 2026 |
About CLX
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorind... [Read more]
Financial Performance
In fiscal year 2026, The Clorox Company's revenue was $6.72 billion, a decrease of -5.41% compared to the previous year's $7.10 billion. Earnings were $587.00 million, a decrease of -27.53%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for CLX stock is "Hold." The 12-month stock price target is $97.47, which is an increase of 13.07% from the latest price.
News
Clorox price target lowered to $91 from $105 at UBS
UBS lowered the firm’s price target on Clorox (CLX) to $91 from $105 and keeps a Neutral rating on the shares.
Clorox price target lowered to $87 from $97 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Clorox (CLX) to $87 from $97 and keeps an Equal Weight rating on the shares.
Clorox price target lowered to $90 from $97 at Citi
Citi analyst Filippo Falorni lowered the firm’s price target on Clorox (CLX) to $90 from $97 and keeps a Neutral rating on the shares. The firm adjusted targets in the…
Clorox price target lowered to $80 from $85 at TD Cowen
TD Cowen analyst Robert Moskow lowered the firm’s price target on Clorox (CLX) to $80 from $85 and keeps a Hold rating on the shares. The firm adjusted targets in…
Clorox Announces November 2 Webcast of First-Quarter Fiscal Year 2027 Results
OAKLAND, Calif., Oct. 12, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its first-quarter fiscal year 2027 results on November 2, 2026.
The Clorox Company Proxy statement: Proxy filing
The Clorox Company filed a proxy statement on October 7, 2026, providing details for shareholder voting and corporate governance matters.
The Clorox Company Proxy statement: Proxy filing
The Clorox Company filed a proxy statement on October 7, 2026, providing details for shareholder voting and corporate governance matters.
Clorox price target lowered to $85 from $90 at TD Cowen
TD Cowen lowered the firm’s price target on Clorox (CLX) to $85 from $90 and keeps a Hold rating on the shares. The firm is reducing its FY27 EPS view…
The Clorox Company Announces the Official Launch of Clorox Purell ProCare™
The new B2B-focused business, created through the combination of CloroxPro and GOJO, Makers of Purell, brings professional and healthcare customers unparalleled access to the most trusted health and h...
HIDDEN VALLEY® INTRODUCES SPOOKY RANCH: THE ICONIC DRESSING TAKES ON A HAUNTING HUE FOR HALLOWEEN
Give your snacks a ghoulish glow-up this season with Hidden Valley's first limited edition holiday release in a glow-in-the-dark bottle. Key Highlights: What It Is: Hidden Valley Ranch's first-ever se...
Clorox Declares Regular Quarterly Dividend of $1.25 Per Share
OAKLAND, Calif., Sept. 23, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.25 per share on the company's common ...
Clorox price target lowered to $97 from $100 at Citi
Citi lowered the firm’s price target on Clorox (CLX) to $97 from $100 and keeps a Neutral rating on the shares after meeting with management.
The Clorox Company Transcript: Boston Global Staples Conference 2026
Leadership transition is underway with a focus on strategic priorities. Fiscal 2027 outlook is for modest organic growth, margin recovery, and continued investment in innovation, especially in health and hygiene following the GOJO acquisition. Inflation and cost pressures are being managed through targeted pricing and productivity gains.
Clorox put volume heavy and directionally bearish
Bearish flow noted in Clorox (CLX) with 1,650 puts trading, or 1.3x expected. Most active are Oct-26 85 puts and Sep-26 95 puts, with total volume in those strikes near…
3 Cheap Stocks Offering Attractive Income
Buy these undervalued dividend stocks that have healthy yields to generate dependable income.
Clorox to Present at Barclays Global Consumer Staples Conference
OAKLAND, Calif., Aug. 19, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle and Chief Financial Officer Luc Bellet will participat...
Hidden Valley Ranch dressing may be a victim of this summer's salad scare
As the cyclospora outbreak has made consumers more cautious about salad purchases, one analyst points to sales declines for Clorox's Hidden Valley brand.
Clorox price target lowered to $100 from $102 at BofA
BofA lowered the firm’s price target on Clorox (CLX) to $100 from $102 and keeps a Neutral rating on the shares. FY27 EPS guidance was set “low and wide” as…
Clorox price target raised to $98 from $94 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Clorox (CLX) to $98 from $94 and keeps a Hold rating on the shares.
Clorox price target raised to $95 from $92 at JPMorgan
JPMorgan analyst Andrea Teixeira raised the firm’s price target on Clorox (CLX) to $95 from $92 and keeps an Underweight rating on the shares.
Clorox price target raised to $105 from $100 at UBS
UBS raised the firm’s price target on Clorox (CLX) to $105 from $100 and keeps a Neutral rating on the shares.
Clorox price target raised to $99 from $98 at Evercore ISI
Evercore ISI raised the firm’s price target on Clorox (CLX) to $99 from $98 and keeps an Underperform rating on the shares.
Clorox price target raised to $100 from $97 at Citi
Citi analyst Filippo Falorni raised the firm’s price target on Clorox (CLX) to $100 from $97 and keeps a Neutral rating on the shares.
The Clorox Company Earnings Call Transcript: Q4 2026
FY26 saw strong execution amid inflation and value-seeking trends, with most segments meeting or exceeding expectations and targeted improvements in underperformers. FY27 guidance calls for flat to slightly up organic sales, targeted pricing, persistent inflation, and continued investment in innovation and productivity, with GOJO integration progressing well.
The Clorox Company Earnings release: Q4 2026
The Clorox Company released its Q4 2026 earnings on August 3, 2026, summarizing the period's financial results.